NY, NJ, CT to follow federal 'pause' of Johnson & Johnson vaccine

COVID-19 Vaccine
Photo credit Getty Images

NEW YORK (1010 WINS) -- New York, New Jersey and Connecticut officials on Tuesday announced that they would follow the federal "pause" of the Johnson & Johnson vaccine.

New York state residents who have J&J vaccine appointments at a state-run mass vaccination site on Tuesday will get the Pfizer vaccine instead, Health Commissioner Howard Zucker said in a statement.

"Today the CDC and FDA issued a statement recommending a pause in the use of the Johnson & Johnson vaccine out of an abundance of caution," he said. "New York State will follow the CDC and FDA recommendation and pause the use of the Johnson & Johnson vaccine statewide immediately today while these health and safety agencies evaluate next steps."

"As the CDC and FDA have said, any adverse events related to the Johnson & Johnson vaccine 'appear to be extremely rare," he added. "People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider."

New Jersey Health Commissioner Judy Persichilli said Tuesday that all of the state’s vaccination sites will cancel or postpone appointments for the J&J vaccine.

Gov. Phil Murphy said the state will work with facilities to provide Pfizer or Moderna vaccines instead.

Gov. Ned Lamont posted a statement on Twitter from the Connecticut Department of Public Health announcing that his state would also temporarily stop administering the J&J COVID-19 vaccine.

In a joint statement, the Centers for Disease Control and Prevention and the Food and Drug Administration said they will stop administering the single-dose shot to investigate clotting reports.

"Right now, these adverse events appear to be extremely rare," the statement read. "Treatment of this specific type of blood clot is different from the treatment that might typically be administered."

Featured Image Photo Credit: Getty Images